In addition to being the target tumor antigen that specifically expressed in AML-LSCs and LPCs, TIM3 is also, interestingly, an exhaustion marker of various immune cells, including T and NK cells [42–44]. This evidence concerns the gene HAVCR2 and neoplasm.